{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T20:32:47Z","timestamp":1757622767622,"version":"3.44.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The treatment outcomes for children and adolescents with rhabdomyosarcoma (RMS) in low-income countries are poor. However, there is a paucity of literature on RMS and its management outcomes in low-resource settings. We evaluated the treatment of RMS with the aim of identifying prognostic factors during management to improve outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We sourced data on children under 18 years treated for rhabdomyosarcoma at the Uganda Cancer Institute between January 2016 and December 2020. Kaplan-Meier survival analysis and Cox\u2019s proportional hazards model were used for five-year survival analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>One hundred twenty-eight RMS cases were identified, with a median age of 6.0 years (IQR 3.6\u201310.0). The most common primary tumour site was the head and neck region, comprising non-parameingeal sites, 37 (28.9%); parameingeal sites, 32 (25.0%); and orbital tumours, 17 (13.3%). Overall, 68 (53.1%) of the primary tumour sites were unfavourable sites. Seventeen (13.3%) patients had metastatic disease at diagnosis, primarily to the lungs, 11 (64.8%). Embryonal and alveolar RMS accounted for 50.0% and 20.3% of the cases, respectively. Only 31 (24.2%) of the patients underwent surgery, and 36 (28.1%) were irradiated. The treatment completion rate was 33.6%, while 46.1% abandoned treatment. Only 25 (19.5%) patients were alive at the time of the study, 65 (50.8%) had died, and 38 (29.7%) had an unknown status. The five-year overall and event-free survival rates were 35% and 30%, respectively. Orbital primary tumour site (HR\u2009=\u20092.86; 95% CI 1.12\u20137.31; <jats:italic>p<\/jats:italic>\u2009=\u20090.028), metastatic disease (HR\u2009=\u20094.09; 95% CI 2.01\u20138.31; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), elevated serum lactate dehydrogenase at diagnosis above 400 U\/L (HR\u2009=\u20092.80; 95% CI 1.46\u20135.33; <jats:italic>p<\/jats:italic>\u2009=\u20090.002), and lack of local control (HR\u2009=\u20093.33; 95% CI 1.34\u20138.29; <jats:italic>p<\/jats:italic>\u2009=\u20090.010) were significant factors for poor survival.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Rhabdomyosarcoma outcomes in Ugandan children are largely poor, with high treatment abandonment and mortality. Concerted, multidisciplinary efforts are needed to improve outcomes in this setting.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12885-025-14735-3","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T06:29:38Z","timestamp":1754893778000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictors of survival among children and adolescents with rhabdomyosarcoma treated in a single resource-limited centre \u2014Uganda"],"prefix":"10.1186","volume":"25","author":[{"given":"Richard","family":"Nyeko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadhil","family":"Geriga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Racheal","family":"Angom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyce Balagadde","family":"Kambugu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaques","family":"van Heerden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"key":"14735_CR1","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s12098-12017-12315-12093","volume":"84","author":"SP Panda","year":"2017","unstructured":"Panda SP, Chinnaswamy G, Vora T, Prasad M, Bansal D, Kapoor G, et al. Diagnosis and management of rhabdomyosarcoma in children and adolescents: ICMR consensus document. Indian J Pediatr. 2017;84:393\u2013402. https:\/\/doi.org\/10.1007\/s12098-12017-12315-12093.","journal-title":"Indian J Pediatr"},{"key":"14735_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27708","author":"R Papyan","year":"2019","unstructured":"Papyan R, Tamamyan G, Danielyan S, Tananyan A, Muradyan A, Saab R. Identifying barriers to treatment of childhood rhabdomyosarcoma in resource-limited settings: a literature review. Pediatr Blood Cancer. 2019. https:\/\/doi.org\/10.1002\/pbc.27708.","journal-title":"Pediatr Blood Cancer"},{"key":"14735_CR3","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1002\/cncr.24465","volume":"115","author":"S Ognjanovic","year":"2009","unstructured":"Ognjanovic S, Linabery AM, Charbonneau B, Ross JA. Trends in childhood rhabdomyosarcoma incidence and survival in the united states, 1975\u20132005. Cancer. 2009;115:4218\u201326.","journal-title":"Cancer"},{"issue":"2","key":"14735_CR4","first-page":"40","volume":"1","author":"AVD Schyff","year":"2010","unstructured":"Schyff AVD, Daniela C, Stefan. Clinical characteristics and outcome of rhabdomyosarcoma in South African children. Afr J Haematol Oncol. 2010;1(2):40\u20137.","journal-title":"Afr J Haematol Oncol"},{"key":"14735_CR5","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.rx.2016.09.003","volume":"58","author":"SM C\u00f3rdoba Rovira","year":"2016","unstructured":"C\u00f3rdoba Rovira SM, Inarejos Clemente EJ. Childhood rhabdomyosarcoma. Radiologia. 2016;58:481\u201390.","journal-title":"Radiologia"},{"key":"14735_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2333794X19849749","volume":"6","author":"I Mutyaba","year":"2019","unstructured":"Mutyaba I, Wabinga HR, Orem J, Casper C, Phipps W. Presentation and outcomes of childhood cancer patients at Uganda cancer institute. Glob Pediatr Health. 2019;6:1\u201312. https:\/\/doi.org\/10.1177\/2333794X19849749.","journal-title":"Glob Pediatr Health"},{"key":"14735_CR7","doi-asserted-by":"publisher","unstructured":"Stephen X, Skapek A, Ferrari AA, Gupta PJ, Lupo E, Butler J, Shipley, et al. Rhabdomyosarcoma. Nat Rev. 2019;5(1). https:\/\/doi.org\/10.1038\/s41572-41018-40051-41572.","DOI":"10.1038\/s41572-41018-40051-41572"},{"issue":"4","key":"14735_CR8","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1200\/JCO.2003.01.032","volume":"21","author":"AS Pappo","year":"2003","unstructured":"Pappo AS, Meza JL, Donaldson SS, et al. Treatment of localized non-orbital, nonparameningeal head and neck rhabdomyosarcoma: lessons learnt from intergroup rhabdomyosarcoma studies III and IV. J Clin Oncol. 2003;21(4):638\u201345.","journal-title":"J Clin Oncol"},{"issue":"12","key":"14735_CR9","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1200\/JCO.2001.3019.3012.3091","volume":"19","author":"WM Crist","year":"2001","unstructured":"Crist WM, Anderson JR, Meza JL, Fryer C, Raney RB, Ruymann FB, et al. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol. 2001;19(12):3091\u2013102. https:\/\/doi.org\/10.1200\/JCO.2001.3019.3012.3091.","journal-title":"J Clin Oncol."},{"key":"14735_CR10","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1200\/JCO.1995.13.8.2123","volume":"13","author":"AS Pappo","year":"1995","unstructured":"Pappo AS, Shapiro DN, Crist WM, et al. Biology and therapy of pediatric rhabdomyosarcoma. J Clin Oncol. 1995;13:2123\u201339.","journal-title":"J Clin Oncol"},{"key":"14735_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/13577140120048890","volume":"5","author":"RB Raney","year":"2001","unstructured":"Raney RB, Maurer HM, Anderson JR, Andrassy RJ, Donaldson SS, Qualman SJ, et al. The intergroup rhabdomyosarcoma study group (IRSG): major lessons from the IRS-I through IRS-IV studies as background for the current IRS-V treatment protocols. Sarcoma. 2001;5:9\u201315.","journal-title":"Sarcoma"},{"issue":"10","key":"14735_CR12","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1200\/JCO.2010.30.4469","volume":"29","author":"RB Raney","year":"2011","unstructured":"Raney RB, Walterhouse DO, Meza JL, Andrassy RJ, Breneman JC, Crist WM, et al. Results of the intergroup rhabdomyosarcoma study group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: a report from the soft tissue sarcoma committee of the children\u2019s oncology group. J Clin Oncol. 2011;29(10):1312\u20138.","journal-title":"J Clin Oncol"},{"key":"14735_CR13","first-page":"284","volume":"5","author":"Y Bhurgri","year":"2004","unstructured":"Bhurgri Y, Bhurgri A, Puri R, et al. Rhabdomyosarcoma in Karachi 1998\u20132002. Asian Pac J Cancer Prev. 2004;5:284\u201390.","journal-title":"Asian Pac J Cancer Prev"},{"key":"14735_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/978-1-4615-6121-7_14","volume":"91","author":"AS Pappo","year":"1997","unstructured":"Pappo AS, Pratt CB. Soft tissue sarcomas in children. Cancer Treat Res. 1997;91:205\u201322.","journal-title":"Cancer Treat Res"},{"issue":"1","key":"14735_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/pbc.22173","volume":"54","author":"L Hessissen","year":"2010","unstructured":"Hessissen L, Kanouni L, Kili A, Nachef MN, El Khorassani M, Benjaafar N. Pediatric rhabdomyosarcoma in Morocco. Pediatr Blood Cancer. 2010;54(1):25\u20138. https:\/\/doi.org\/10.1002\/pbc.22173.","journal-title":"Pediatr Blood Cancer"},{"key":"14735_CR16","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1200\/JCO.2004.08.124","volume":"22","author":"MD Wharam","year":"2004","unstructured":"Wharam MD, Meza J, Anderson J, Breneman JC, Donaldson SS, Fitzgerald TJ, et al. Failure pattern and factors predictive of local failure in rhabdomyosarcoma: A report of group III patients on the third intergroup rhabdomyosarcoma study. J Clin Oncol. 2004;22:22:1902\u20138.","journal-title":"J Clin Oncol"},{"key":"14735_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3109\/08880018.08882011.08650836","volume":"29","author":"C Akyuz","year":"2012","unstructured":"Akyuz C, Sar\u0131 N, Yalc\u00b8\u0131n B, Varan A, Kutluk T, B\u00a8uy\u00a8ukpamukc\u00b8u M. Long-Term survival results of pediatric rhabdomyosarcoma patients: A Single-Center experience from Turkey. Pediatr Hematol Oncol. 2012;29:38\u201349. https:\/\/doi.org\/10.3109\/08880018.08882011.08650836.","journal-title":"Pediatr Hematol Oncol"},{"key":"14735_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4103\/CRST.CRST_14_19","volume":"2","author":"LP Bhuvan","year":"2019","unstructured":"Bhuvan LP, Radhakrishnan V, Raja A, Ganesarajah S, Sagar TG. Outcomes in rhabdomyosarcoma: experience from a tertiary cancer center in India. Cancer Res Stat Treat. 2019;2:4\u20139.","journal-title":"Cancer Res Stat Treat"},{"issue":"14","key":"14735_CR19","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1200\/JCO.2007.14.7207","volume":"26","author":"O Oberlin","year":"2008","unstructured":"Oberlin O, Rey A, Lyden E, Bisogno G, Stevens MC, Meyer WH, et al. Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from united states and European cooperative groups. J Clin Oncol. 2008;26(14):2384\u20139.","journal-title":"J Clin Oncol"},{"issue":"24","key":"14735_CR20","doi-asserted-by":"publisher","first-page":"3844","DOI":"10.1200\/JCO.2005.05.3801","volume":"24","author":"JL Meza","year":"2006","unstructured":"Meza JL, Anderson J, Pappo AS, Meyer WH. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the children\u2019s oncology group. J Clin Oncol. 2006;24(24):3844\u201351.","journal-title":"J Clin Oncol"},{"key":"14735_CR21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/tropej\/fmv005","volume":"61","author":"DC Stefan","year":"2015","unstructured":"Stefan DC. Patterns of distribution of childhood cancer in Africa. J Trop Pediatr. 2015;61:165\u201373.","journal-title":"J Trop Pediatr"},{"key":"14735_CR22","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.21873\/invivo.13040","volume":"36","author":"L Wen-Ling","year":"2022","unstructured":"Wen-Ling L, Wei-Hao H, Chien-Fu Y. Clinicopathological Features and Prognostic Factors of Sinonasal Rhabdomyosarcoma. In vivo. 2022;36:2965\u201372. https:\/\/doi.org\/10.21873\/invivo.13040.","journal-title":"In vivo."},{"key":"14735_CR23","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P. Nonparametric Estimation from incomplete observations. J Am Statist Ass. 1958;53:457\u201381.","journal-title":"J Am Statist Ass"},{"key":"14735_CR24","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR. Regression models and life tables. J R Stat Soc B. 1972;34:187\u2013220.","journal-title":"J R Stat Soc B"},{"issue":"1","key":"14735_CR25","first-page":"51","volume":"18","author":"HH Abd El-Aal","year":"2006","unstructured":"Abd El-Aal HH, Habib EE, Mishrif MM. Rhabdomyosarcoma: the experience of the pediatric unit of Kasr El-Aini center of radiation oncology and nuclear medicine (NEMROCK) (from January 1992 to January 2001). J Egypt Natl Canc Inst. 2006;18(1):51\u201360.","journal-title":"J Egypt Natl Canc Inst"},{"key":"14735_CR26","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ejca.2021.04.007","volume":"151","author":"H Glosli","year":"2021","unstructured":"Glosli H, Bisogno G, Kelsey A, Chisholm JC, Gaze M, Kolb F, et al. Non-parameningeal head and neck rhabdomyosarcoma in children, adolescents, and young adults: experience of the European paediatric soft tissue sarcoma study group (EpSSG) - RMS2005 study. Eur J Cancer. 2021;151:84\u201393.","journal-title":"Eur J Cancer"},{"issue":"23","key":"14735_CR27","doi-asserted-by":"publisher","first-page":"4071","DOI":"10.1002\/cncr.35497","volume":"130","author":"HC Mandeville","year":"2024","unstructured":"Mandeville HC, Bisogno G, Minard-Colin V, Alaggio R, Ben-Arush M, Chargari C, et al. Localized incompletely resected standard risk rhabdomyosarcoma in children and adolescents: Results from the European Paediatric Soft Tissue Sarcoma Study Group RMS 2005 trial. Cancer. 2024;130(23):4071\u201384. https:\/\/doi.org\/10.1002\/cncr.35497.","journal-title":"Cancer."},{"key":"14735_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4103\/0189-6725.41631","volume":"5","author":"FA Uba","year":"2008","unstructured":"Uba FA, Chirdan LB. Clinical characteristics and outcome of surgical treatment of childhood rhabdomyosarcoma: a 7-year experience. Afr J Paediatr Surg. 2008;5:19\u201323.","journal-title":"Afr J Paediatr Surg"},{"key":"14735_CR29","doi-asserted-by":"publisher","unstructured":"Badr MA, Al-Tonbary YA, Mansour AK, Hassan TH, Beshir MR, Darwish A, et al. Epidemiological characteristics and survival studies of rhabdomyosarcoma in East Egypt: a five-year multicenter study. ISRN Oncology. 2012;8. https:\/\/doi.org\/10.5402\/2012\/674523.","DOI":"10.5402\/2012\/674523"},{"key":"14735_CR30","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/ped1004.12220","volume":"4","author":"X Wang","year":"2020","unstructured":"Wang X, Feng J, Li Z, Zhang X, Chen J, Feng G. Characteristics and prognosis of embryonal rhabdomyosarcoma in children and adolescents: an analysis of 464 cases from the SEER database. Pediatr Investig. 2020;4:242\u20139.https:\/\/doi.org\/10.1002\/ped1004.12220.","journal-title":"Pediatr Investig"},{"issue":"2","key":"14735_CR31","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2214\/AJR.2216.17466","volume":"209","author":"JR Kim","year":"2017","unstructured":"Kim JR, Yoon HM, Koh K-N, Jung AY, Cho YA, Lee JS. Rhabdomyosarcoma in children and adolescents: Patterns and risk factors of distant metastasis. AJR Am J Roentgenol. 2017;209(2):409\u201316. https:\/\/doi.org\/10.2214\/AJR.2216.17466.","journal-title":"AJR Am J Roentgenol"},{"key":"14735_CR32","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/s10147-015-0918-0","volume":"21","author":"MA Kashtan","year":"2016","unstructured":"Kashtan MA, Jayakrishnan TT, Rajeev R, Charlson JC, Johnston F, Clark Gamblin T, et al. Age-based disparities in treatment and outcomes of retroperitoneal rhabdomyosarcoma. Int J Clin Oncol. 2016;21:602\u20138.","journal-title":"Int J Clin Oncol"},{"issue":"2","key":"14735_CR33","doi-asserted-by":"publisher","first-page":"e243","DOI":"10.1016\/j.jss.011.1003.1001","volume":"170","author":"EA Perez","year":"2011","unstructured":"Perez EA, Kassira N, Cheung MC, Koniaris LG, Neville HL, Sola JE. Rhabdomyosarcoma in children: a SEER population based study. J Surg Res. 2011;170(2):e243\u2013251. 210.1016\/j.jss.2011.1003.1001.","journal-title":"J Surg Res"},{"key":"14735_CR34","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1186\/1471-2407-14-654","volume":"14","author":"L Yang","year":"2014","unstructured":"Yang L, Takimoto T, Fujimoto J. Prognostic model for predicting overall survival in children and adolescents with rhabdomyosarcoma. BMC Cancer. 2014;14:654.","journal-title":"BMC Cancer"},{"issue":"1","key":"14735_CR35","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/pbc.10441","volume":"42","author":"D Joshi","year":"2004","unstructured":"Joshi D, Anderson JR, Paidas C, Breneman J, Parham DM, Crist W. Age is an independent prognostic factor in rhabdomyosarcoma: a report from the soft tissue sarcoma committee of the children\u2019s oncology group. Pediatr Blood Cancer. 2004;42(1):64\u201373. https:\/\/doi.org\/10.1002\/pbc.10441.","journal-title":"Pediatr Blood Cancer"},{"issue":"15","key":"14735_CR36","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1002\/cncr.25887","volume":"117","author":"S Malempati","year":"2011","unstructured":"Malempati S, Rodeberg DA, Donaldson SS, Lyden ER, Anderson JR, Hawkins DS, et al. Rhabdomyosarcoma in infants younger than 1 year: a report from the Children\u2019s Oncology Group. Cancer. 2011;117(15):3493\u2013501. https:\/\/doi.org\/10.1002\/cncr.25887.","journal-title":"Cancer"},{"issue":"23","key":"14735_CR37","doi-asserted-by":"publisher","first-page":"4787","DOI":"10.1200\/JCO.2004.4704.4083","volume":"22","author":"M Carli","year":"2004","unstructured":"Carli M, Colombatti R, Oberlin O, Bisogno G, Treuner J, Koscielniak E, et al. European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: Final results and analysis of prognostic factors. J Clin Oncol. 2004;22(23):4787\u201394. https:\/\/doi.org\/10.1200\/JCO.2004.4704.4083.","journal-title":"J Clin Oncol"},{"issue":"1","key":"14735_CR38","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1200\/JCO.2003.1206.1129","volume":"21","author":"JC Breneman","year":"2003","unstructured":"Breneman JC, Lyden E, Pappo AS, Link MP, Anderson JR, Parham DM, et al. Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol. 2003;21(1):78\u201384. https:\/\/doi.org\/10.1200\/JCO.2003.1206.1129.","journal-title":"J Clin Oncol"},{"key":"14735_CR39","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1620\/tjem.213.221","volume":"213","author":"Z Ustuner","year":"2007","unstructured":"Ustuner Z, Basaran M, Dizdar Y, Agaoglu FY, Bilgic B, Sakar B, et al. Clinical outcome of rhabdomyosarcoma in adolescents and adult patients: single center experience from Turkey. Tohoku J Exp Med. 2007;213:221\u20139.","journal-title":"Tohoku J Exp Med"},{"key":"14735_CR40","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1200\/JCO.1995.13.3.610","volume":"13","author":"W Crist","year":"1995","unstructured":"Crist W, Gehan EA, Ragab AH, et al. The third intergroup rhabdomyosarcoma study. J Clin Oncol. 1995;13:610\u201330.","journal-title":"J Clin Oncol"},{"key":"14735_CR41","doi-asserted-by":"publisher","first-page":"4058","DOI":"10.1200\/JCO.2001.19.20.4058","volume":"19","author":"LM Smith","year":"2001","unstructured":"Smith LM, Anderson JR, Qualman SJ, et al. Which patients with microscopic disease and rhabdomyosarcoma experience relapse after therapy? A report from the soft tissue sarcoma committee of the children\u2019s oncology group. J Clin Oncol. 2001;19:4058\u201364.","journal-title":"J Clin Oncol"},{"issue":"11","key":"14735_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29311","volume":"68","author":"B Atwiine","year":"2021","unstructured":"Atwiine B, Busingye I, Kyarisiima R, Baluku E, Mbabazi R, Bamwine B, et al. Money was the problem: caregivers\u2019 self-reported reasons for abandoning their children\u2019s cancer treatment in Southwest Uganda. Pediatr Blood Cancer. 2021;68(11): e29311.","journal-title":"Pediatr Blood Cancer"},{"key":"14735_CR43","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1002\/pbc.21127","volume":"49","author":"RS Arora","year":"2007","unstructured":"Arora RS, Eden T, Pizer B. The problem of treatment abandonment in children from developing countries with cancer. Pediatr Blood Cancer. 2007;49:941\u20136.","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"14735_CR44","doi-asserted-by":"publisher","first-page":"e29556","DOI":"10.21002\/pbc.29556","volume":"69","author":"C Monsereenusorn","year":"2022","unstructured":"Monsereenusorn C, Alcasabas AP, Loh AHP, Soh SY, Leung KWP, Kimpo M, et al. Impact of treatment refusal and abandonment on survival outcomes in pediatric osteosarcoma in Southeast Asia: A multicenter study. Pediatr Blood Cancer. 2022;69(4):e29556. https:\/\/doi.org\/10.21002\/pbc.29556.","journal-title":"Pediatr Blood Cancer"},{"key":"14735_CR45","first-page":"40","volume":"1","author":"A Van Der Schyff","year":"2010","unstructured":"Van Der Schyff A, Fcpaed M, Stefan PDC. Clinical characteristics and outcome of rhabdomyosarcoma in South African children. Afr J Haematol Oncol. 2010;1:40\u20137.","journal-title":"Afr J Haematol Oncol"},{"issue":"6","key":"14735_CR46","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1002\/pbc.21699","volume":"51","author":"F Antillon","year":"2008","unstructured":"Antillon F, Castellanos M, Valverde P, Luna-Fineman S, Garrido C, Serrato T, et al. Treating pediatric soft tissue sarcomas in a countrywith limited resources: the experience of the Unidad Nacional de Oncologia Pediatrica in Guatemala. Pediatr Blood Cancer. 2008;51(6):760\u20134. https:\/\/doi.org\/10.1002\/pbc.21699.","journal-title":"Pediatr Blood Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14735-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14735-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14735-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T23:21:00Z","timestamp":1757373660000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14735-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14735"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14735-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"type":"electronic","value":"1471-2407"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"31 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations, and the study was conducted in accordance with the Declaration of Helsinki. The study was approved by the Uganda Cancer Institute Research and Ethics Committee (UCIREC-2022-45). Where a phone call to ascertain a child\u2019s status was required, informed verbal consent was obtained from the parents or guardians at the point of introduction during the call.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1299"}}